JAK2 and COVID-19: We identified several key proteins of the JAK‐STAT pathway (JAK2, STAT1, STAT3, and STAT4), a main regulator of the inflammatory response, that has been suggested as a potential target to treat COVID‐19 (Bagca & Avci, 2020).